GEMCITABINE DERIVATIVE, COMPOSITION CONTAINING THE DERIVATIVE AND PHARMACEUTICAL USE OF THE DERIVATIVE
    15.
    发明公开
    GEMCITABINE DERIVATIVE, COMPOSITION CONTAINING THE DERIVATIVE AND PHARMACEUTICAL USE OF THE DERIVATIVE 审中-公开
    GEMCITABIN-DERIVATE,ZUSAMMENSETZUNG MIT DIESEM DERIVAT UND PHARMAZUTISCHE VERWENDUNG DES DERIVATS

    公开(公告)号:EP3078671A4

    公开(公告)日:2017-05-31

    申请号:EP14867802

    申请日:2014-12-04

    摘要: The invention provides gemcitabine derivatives shown in the following formula (I) and preparation methods thereof. The invention further relates to a pharmaceutical composition which comprising the said gemcitabine derivatives in an effective amount and a pharmaceutically acceptable excipient or additive. The invention further provides use of the said derivatives for preparing anti-tumor drugs. The compound designed by the invention is novel in structure and has a remarkable anti-tumor activity. According to the compound designed by the invention, the preparation starting materials have extensive sources and are easily obtained, the preparation method is simple and easy to operate, and the yield of the product is high, so that industrial production on a large scale is facilitated.

    摘要翻译: 本发明提供下式(I)所示的吉西他滨衍生物及其制备方法。 本发明还涉及包含有效量的所述吉西他滨衍生物和药学上可接受的赋形剂或添加剂的药物组合物。 本发明进一步提供了所述衍生物用于制备抗肿瘤药物的用途。 本发明设计的化合物结构新颖,具有显着的抗肿瘤活性。 根据本发明设计的化合物,制备原料来源广泛,易得,制备方法简单易操作,产品收率高,便于大规模工业化生产 。

    METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID
    17.
    发明公开
    METHOD FOR LIQUID-PHASE SYNTHESIS OF NUCLEIC ACID 审中-公开
    VERFAHREN ZURFLÜSSIGPHENSENSNNESESVONNUKLEINSÄUREN

    公开(公告)号:EP2921499A4

    公开(公告)日:2016-04-27

    申请号:EP13854700

    申请日:2013-11-13

    摘要: In this method, an oligonucleotide is prepared by using, as a synthesis unit, a novel nucleoside monomer compound represented by formula (I) [wherein X, R 1 , Y, Base, Z, Ar, R 2 , R 3 and n are each as defined in Claim 1]. The novel nucleoside monomer compound is a nucleoside, the base moiety of which is substituted with an aromatic-hydrocarbon-ring-carbonyl or -thiocarbonyl group having at least one hydrophobic group. The method can dispense with column-chromatographic purification in every reaction, and enables base elongation not only in the 3'-direction but also in the 5'-direction, thus attaining efficient liquid-phase mass synthesis of an oligonucleotide.

    摘要翻译: 在该方法中,通过使用由式(I)表示的新型核苷单体化合物[其中X,R 1,Y,碱,Z,Ar,R 2,R 3和n为 如权利要求1所定义。 新型核苷单体化合物是一种核苷,其碱基部分被具有至少一个疏水基团的芳香烃 - 羰基 - 羰基或硫代羰基取代。 该方法可以避免每次反应中的色谱纯化,不仅能在3'方向而且在5'方向上进行碱基延伸,从而获得有效的液相合成寡核苷酸。